A detailed history of Golden State Equity Partners transactions in Sanofi stock. As of the latest transaction made, Golden State Equity Partners holds 2,316 shares of SNY stock, worth $112,858. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,316
Holding current value
$112,858
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$48.54 - $58.53 $112,418 - $135,555
2,316 New
2,316 $133,000
Q1 2023

Jun 01, 2023

SELL
$45.86 - $54.45 $394,396 - $468,270
-8,600 Closed
0 $0
Q1 2022

May 18, 2022

BUY
$48.48 - $53.65 $416,928 - $461,390
8,600 New
8,600 $442,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $122B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.